Real-World Experience of Upadacitinib Dosing Reduction in Patients with Moderate Atopic Dermatitis: A Case Series Study in Taiwan

Dermatol Pract Concept. 2024 Jul 1;14(3):e2024186. doi: 10.5826/dpc.1403a186.
No abstract available

Publication types

  • Letter